Other studies have revealed that excessive NLRP3 activation is implicated in diseases driven by metabolic dysfunction such as type 2 diabetes and nonalcoholic steatohepatitis, in neurodegenerative diseases including Alzheimer’s disease and Parkinson’s disease, and in cancer [142,143,144,145]. The gene discussed is NLRP3; the disease is type 2 diabetes mellitus.